[1]黄莉荣,薛 征.基于Th1/Th2失衡探讨再生障碍性贫血中西医治疗研究进展[J].陕西中医,2021,(11):1644-1647,1651.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.034]
　HUANG Lirong,XUE Zheng.Discussion on treatment progress of traditional Chinese and western medicine of aplastic anemia based on Th1/Th2[J].,2021,(11):1644-1647,1651.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.034]
点击复制

基于Th1/Th2失衡探讨再生障碍性贫血中西医治疗研究进展
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年11期
页码:
1644-1647,1651
栏目:
综 述
出版日期:
2021-11-05

文章信息/Info

Title:
Discussion on treatment progress of traditional Chinese and western medicine of aplastic anemia based on Th1/Th2
作者:
黄莉荣; 薛 征
(上海中医药大学附属市中医医院,上海 200071)
Author(s):
HUANG Lirong; XUE Zheng
(Shanghai Municipal Hospital of Traditional Chinese Medicine,Shanghai 200071,China)
关键词:
再生障碍性贫血;  辅助型T细胞1/辅助型T细胞2;  靶点;  免疫调节;  造血
Keywords:
Aplastic anemia;  Th1/Th2;  Target;  Immune regulation;  Promoting hematopoiesis
分类号:
R 725
DOI:
DOI:10.3969/j.issn.1000-7369.2020.11.034
文献标志码:
A
摘要:
再生障碍性贫血(AA)是一种以T细胞免疫功能异常为主的骨髓造血衰竭性疾病,现代中医学将其归属于“髓劳”范畴。目前认为免疫调节机制的紊乱尤其是Th1/Th2失衡在AA发病中起着关键作用。近年来,发现一些新靶点对于调节Th1和Th2平衡具有显著作用,这些靶点作用包括抑制Th1细胞的增殖、调节Th1和Th2细胞的分化及相关基因的表达、调控细胞信号传导等方面。研究证实,传统中医药通过多靶点、多途径的方式调控Th1和Th2失衡同样行之有效。补肾益髓法、健脾补肾法、益气养血法治疗AA以及中药人参、三七、马齿苋的有效成分,在调节免疫、促进造血及减轻药物不良反应方面发挥了重要作用。因此,探索针对Th1和Th2失衡可能存在的新靶点,总结中医中药对Th1/Th2干预的研究进展,这为中西医结合治疗AA提供了巨大潜力。
Abstract:
Aplastic anemia(AA)is a debilitating disease of bone marrow hematopoiesis mainly caused by abnormal T cell immune function.In modern Chinese medicine,it is classified as a “Suilao”.At present,it is believed that the disorder of immune regulation mechanism,especially the imbalance of Th1/Th2,plays a key role in the pathogenesis of AA.In recent years,some new targets have been found to have significant effects on the regulation of Th1 and Th2 balance,including inhibition of Th1 cell proliferation,regulation of Th1 and Th2 cell differentiation and expression of related genes,and regulation of cell signal transduction.Studies confirm that traditional Chinese medicine regulation of Th1 and Th2 imbalance is also effective through multiple target and pathways,Bushen formula,tonifying spleen and kidney,nourishing Qi and blood and the active components of traditional Chinese medicine ginseng,notoginseng,purslane plays an important role in regulating immunity,promoting hematopoiesis and reducing the side effects of drugs.Therefore,exploring possible new targets for Th1 and Th2 imbalance and summarizing the research progress of TCM intervention on Th1/Th2 provide great potential for the treatment of AA with integrated Chinese and western medicine.

参考文献/References:

[1] 王月莉,严萍丽.环孢素与雄激素配伍治疗再生障碍性贫血36例[J].陕西医学杂志,2016,45(1):122-123.
[2] 曹 琰.抗胸腺细胞球蛋白治疗慢性再生障碍性贫血的疗效观察[J].陕西医学杂志,2016,45(8):995-996.
[3] Guan J,Sun YY,Fu R,et al.A cohort study of immune and hematopoietic functionality changes in severe aplastic anemia patients treated with immunosuppressive therapy[J].Medicine(Baltimore),2019,98(3):1-6.
[4] 柯福彬,Kumar Y,谢晓恬,等.再生障碍性贫血患儿骨髓T-bet、GATA3蛋白和外周血细胞因子表达及意义[J].同济大学学报:医学版,2019,39(1):80-84.
[5] Zheng MY,Liu CY,Fu R,et al.Abnormal immunomodulatory ability on memory T cells in humans with severe aplastic anemia[J].International Journal of Clinical and Experimental Pathology,2015,8(4):3659-3669.
[6] Liu CY,Sun YY,Shao ZH.Current concepts of the pathogenesis of aplastic anemia[J].Curr Pharm Des,2019,25(3):236-241.
[7] Liu CY,Zheng MY,Wang T,et al.PKM2 is required to activate myeloid dendritic cells from patients with severe aplastic anemia[J].Oxidative Medicine and Cellular Longevity,2018(2018):1-9.
[8] 何亚利,梁顺容,钟一梅.T淋巴细胞亚群与炎性因子在评估再生障碍性贫血病情及预后中的应用[J].国际检验医学杂志,2015,36(17):2516-2518.
[9] Medinger M,Drexler B,Lengerke C,et al.Pathogenesis of acquired aplastic anemia and the role of the bone marrow microenvironment[J].Front Oncol,2018,8(587):1-10.
[10] Gandhi AK,Kim WM,Sun ZJ,et al.High resolution X-ray and NMR structural study of human T-cell immunoglobulin and mucin domain containing protein-3[J].Sci Rep,2018,8(1):1-13.
[11] Shan NN,Hu Y,Liu X,et al.Imbalanced expression of Tbet and T cell immunoglobulin mucin-3 in patients with aplastic anaemia[J].J Clin Immunol,2013(33):809-816.
[12] Pereira RM,Hogan PG,Rao A,et al.Transcriptional and epigenetic regulation of T cell hyporesponsiveness[J].Journal of Leukocyte Biology,2017,102(3):1-15.
[13] Catakovic K,Klieser E,Neureiter D,et al.T cell exhaustion:From pathophysiological basics to tumor immunotherapy[J].Cell Communication and Signaling,2017,15(1):1-15.
[14] Liu X,Cui X,Yuan D,et al.Altered expression of T cell immunoglobulin-mucin(Tim)molecules in peripheral blood mononuclear cells in aplastic anemia[J].Cancer Cell International,2014,14(1):1-5.
[15] Pech M,Weckmann M,Konig IR,et al.Rhinovirus infections change DNA methylation and mRNA expression in children with asthma[J].PLoS One,2018,13(11):1-18.
[16] Gu D,Ao X,Yang Y,et al.Soluble immune checkpoints in cancer:Production,function and biological significance[J].J Immunother Cancer,2018,6(1):132.
[17] 贺 欣,王化泉,邵宗鸿.Tim3和BAT3在再生障碍性贫血中免疫机制的研究进展[J].中国免疫学杂志,2020,36(5):630-633.
[18] Toba T,Murata K,Nakanishi K,et al.Minimum structure requirement of immunomodulatory glycolipids for predominant Th2 cytokine induction and the discovery of non-linear phytosphingosine analogs[J].Bioorganic & Medicinal Chemistry Letters,2007,17(10):2781-2784.
[19] Velmourougane G,Raju R,Bricard G,et al.Synthesis and evaluation of an acyl-chain unsaturated analog of the Th2 biasing,immunostimulatory glycolipid,OCH[J].Bioorg Med Chem Lett,2009,19(13):3386-3388.
[20] Qiao XH,Xie XT,Jiang SY,et al.Experimental bone marrow failure in mice ameliorated by OCH via tippling the balance of released cytokines from Th1 to Th2[J].Immunopharmacology and Immunotoxicology,2012,34(3):491-498.
[21] Qiao XH,Xie XT,Shi W,et al.OCH ameliorates bone marrow failure in mice via downregulation of T-bet expression[J].J Immunol Res,2014(14):1-8.
[22] Qiao XH,Xie XT,Shi W,et al.OCH-mediated shift of Th1 and Th2 cytokines by NKT cells in mice with aplastic anemia[J].Medical Oncology(Northwood,London,England),2015,32(3):67.
[23] Margueron R,Reinberg D.The polycomb complex PRC2 and its mark in life[J].Nature,2011,469(30):343-349.
[24] Tong Q,He S,Xie F,et al.Ezh2 regulates transcriptional and posttranslational expression of T-bet and promotes Th1 cell responses mediating aplastic anemia in mice[J].J Immunol,2014,192(11):5012-5022.
[25] Mingueneau M,Roncagalli R,Gregoire C,et al.Loss of the LAT adaptor converts antigen-responsive T cells into pathogenic effectors that function independently of the T cell receptor[J].Immunity,2009,31(2):197-208.
[26] Sheng WW,Liu CY,Fu R,et al.Abnormalities of quantities and functions of linker for activations of T cells in severe aplastic anemia[J].Eur J Haematol,2014,93(3):214-223.
[27] 唐 洪,刘 娜,刘 勇,等.从脾肾论治熟地黄在慢性再生障碍性贫血治疗中的应用[J].陕西中医,2020,41(6):780-782.
[28] 瞿玮颖,邱仲川,赵 琳,等.温肾益髓法治疗肾阳虚型再生障碍性贫血的疗效观察及对Th1/Th2及细胞因子的影响[J].四川中医,2017,35(3):103-106.
[29] 曹宇峰,张琳琳,吕丽丽,等.健脾补肾方对再生障碍性贫血患者免疫T细胞亚群及相关细胞因子的影响[J].河北医药,2020,42(4):508-511,516.
[30] 于天祥.基于IFN-γ/T-bet、IL-4/STAT6信号通路探讨再生障碍性贫血发病机制及补肾健脾祛障方的干预作用[D].济南:山东中医药大学,2017.
[31] 杨思琦.补肾生血法与益气养血法治疗再障的临床观察及对Th1/Th2、T-bet和GATA-3的影响研究[D].哈尔滨:黑龙江中医药大学,2020.
[32] Deng PY,Li X,Wei Y,et al.The herbal decoction modified Danggui Buxue Tang attenuates immune-mediated bone marrow failure by regulating the differentiation of T lymphocytes in an immune-induced aplastic anemia mouse model[J].PLoS One,2017,12(7):180417.
[33] 尹利明,郑智茵,沃立科,等.人参总皂苷促进再生障碍性贫血小鼠造血及其机制探讨[J].中国病理生理杂志,2015,31(4):732-737.
[34] 郑智茵,尹利明,庄海峰,等.人参二醇组皂苷提取物对再生障碍性贫血小鼠免疫调节作用的研究[J].中国药理学通报,2015,31(6):790-795.
[35] Zheng ZY,Yu XL,Dai TY,et al.Panaxdiol saponins component promotes hematopoiesis and modulates T lymphocyte dysregulation in aplastic anemia model mice[J].Chin J Integr Med,2019,25(12):902-910.
[36] Yang ZG,Chen AQ,Sun HX,et al.Ginsenoside Rd elicits Th1 and Th2 immune responses to ovalbumin in mice[J].Vaccine,2007,25(1):161-169.
[37] Zhao YN,Sun XH,Yu XL,et al.Saponins from panax notoginseng leaves improve the symptoms of aplastic anemia and aberrant immunity in mice[J].Biomed Pharmacother,2018(102):959-965.
[38] Askari VR,Rezaee SA,Abnous K.et al.The influence of hydro-ethanolic extract of portulaca oleracea L.on Th1/Th2 balance in isolated human lymphocytes[J].J Ethnopharmacol,2016,82(10):1112-1121.
[39] 张福鹏,赵晓燕,孙伟玲,等.生血合剂及其拆方对慢性再生障碍性贫血患者骨髓单个核细胞血管内皮生长因子的表达影响[J].中国药物与临床,2019,19(23):4057-4058.

相似文献/References:

[1]唐洪屈,刘 娜△,刘 勇,等.从脾肾论治熟地黄在慢性再生障碍性贫血治疗中的应用*[J].陕西中医,2020,(6):780.[doi:DOI:10.3969/j.issn.10007369.2020.06.022]
[2]李 芮,刘 健,靳 楠,等.基于网络药理学探讨当归补血汤治疗再生障碍性贫血作用机制[J].陕西中医,2022,(3):384.[doi:DOI:10.3969/j.issn.1000-7369.2022.03.028]
[3]杨 桐,田春洪,田 原,等.益血生髓颗粒对苯试剂诱导的再生障碍性贫血小鼠造血功能及T细胞亚群的影响[J].陕西中医,2022,(8):1019.[doi:DOI:10.3969/j.issn.1000-7369.2022.08.007]
　YANG Tong,TIAN Chunhong,TIAN Yuan,et al.Effects of Yixue Shengsui granule on hematopoietic function and T cell subsets of benzene reagent-induced aplastic anermia model mice[J].,2022,(11):1019.[doi:DOI:10.3969/j.issn.1000-7369.2022.08.007]
[4]何昊兰,鲁英娟,张小莉,等.健脾生血汤联合促红素治疗再生障碍性贫血疗效及对患者中医症候、炎症因子水平的影响[J].陕西中医,2022,(10):1411.[doi:DOI:10.3969/j.issn.1000-7369.2022.10.021]
　HE Haolan,LU Yingjuan,ZHANG Xiaoli,et al.Effect of Jianpi Shengxue decoction combined with erythropoietin on aplastic anemia and its effect on TCM symptoms and inflammatory factors[J].,2022,(11):1411.[doi:DOI:10.3969/j.issn.1000-7369.2022.10.021]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(81874488); 上海市科学技术委员会科研计划项目(18401903700)
更新日期/Last Update: 2021-11-10